Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Depreciation & Amortization (CF) (2020 - 2026)

Cresco Labs' (CRLBF) quarterly Depreciation & Amortization (CF) came in at $12.2 million in Q1 2026, down 5.35% YoY from $12.9 million in Q1 2025, and up 13.53% on a QoQ basis from $10.8 million in Q4 2025.

Cresco Labs (CRLBF) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $12.2 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 5.35% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.0 million (down 15.26% YoY) and the FY2025 annual result came in at $48.7 million, down 17.57% from the prior year.
  • Depreciation & Amortization (CF) advanced to $12.2 million in Q1 2026, from $10.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $20.3 million in Q4 2023 to a low of $10.8 million in Q4 2025.
  • A 5-year average of $13.8 million and a median of $13.3 million in 2022 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 33.72% — and 2024, when it plunged 31.35%.
  • Tracing CRLBF's Depreciation & Amortization (CF) over 5 years: stood at $13.4 million in 2022, then surged by 51.19% to $20.3 million in 2023, then sank by 31.35% to $13.9 million in 2024, then dropped by 22.62% to $10.8 million in 2025, then increased by 13.53% to $12.2 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $12.2 million (Q1 2026), $10.8 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 241.00 Mn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn -
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn - -
10 Cresco Labs 295.09 Mn 230.98 Mn 86.95 Mn 12.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.22 Mn
Mar 31, 2026 12.22 Mn
Dec 31, 2025 10.76 Mn
Dec 31, 2025 10.76 Mn
Sep 30, 2025 12.86 Mn
Sep 30, 2025 12.86 Mn
Jun 30, 2025 12.19 Mn
Jun 30, 2025 12.19 Mn
Mar 31, 2025 12.91 Mn
Mar 31, 2025 12.91 Mn
Dec 31, 2024 13.90 Mn
Dec 31, 2024 13.90 Mn
Sep 30, 2024 14.93 Mn
Sep 30, 2024 14.93 Mn
Jun 30, 2024 14.93 Mn
Jun 30, 2024 14.93 Mn
Mar 31, 2024 15.33 Mn
Mar 31, 2024 15.33 Mn
Dec 31, 2023 20.25 Mn
Dec 31, 2023 20.25 Mn